328 related articles for article (PubMed ID: 30310143)
1. The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol.
Vujanić GM; Gessler M; Ooms AHAG; Collini P; Coulomb-l'Hermine A; D'Hooghe E; de Krijger RR; Perotti D; Pritchard-Jones K; Vokuhl C; van den Heuvel-Eibrink MM; Graf N;
Nat Rev Urol; 2018 Nov; 15(11):693-701. PubMed ID: 30310143
[TBL] [Abstract][Full Text] [Related]
2. Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.
van den Heuvel-Eibrink MM; Hol JA; Pritchard-Jones K; van Tinteren H; Furtwängler R; Verschuur AC; Vujanic GM; Leuschner I; Brok J; Rübe C; Smets AM; Janssens GO; Godzinski J; Ramírez-Villar GL; de Camargo B; Segers H; Collini P; Gessler M; Bergeron C; Spreafico F; Graf N;
Nat Rev Urol; 2017 Dec; 14(12):743-752. PubMed ID: 29089605
[TBL] [Abstract][Full Text] [Related]
3. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
[TBL] [Abstract][Full Text] [Related]
4. Dataset for the reporting of nephrectomy specimens for Wilms' tumour treated with preoperative chemotherapy: recommendations from the International Society of Paediatric Oncology Renal Tumour Study Group.
Vujanić GM; D'Hooghe E; Vokuhl C; Collini P
Histopathology; 2021 Nov; 79(5):678-686. PubMed ID: 33942359
[TBL] [Abstract][Full Text] [Related]
5. How we approach paediatric renal tumour core needle biopsy in the setting of preoperative chemotherapy: A Review from the SIOP Renal Tumour Study Group.
Jackson TJ; Brisse HJ; Pritchard-Jones K; Nakata K; Morosi C; Oue T; Irtan S; Vujanic G; van den Heuvel-Eibrink MM; Graf N; Chowdhury T;
Pediatr Blood Cancer; 2022 Sep; 69(9):e29702. PubMed ID: 35587187
[TBL] [Abstract][Full Text] [Related]
6. Response to letter commenting on "Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)".
; van den Heuvel-Eibrink MM; Pritchard-Jones K; van Tinteren H; Graf N
Eur J Cancer; 2015 May; 51(8):995-6. PubMed ID: 25840668
[No Abstract] [Full Text] [Related]
7. Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials - A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting.
Brok J; Mavinkurve-Groothuis AMC; Drost J; Perotti D; Geller JI; Walz AL; Geoerger B; Pasqualini C; Verschuur A; Polanco A; Jones KP; van den Heuvel-Eibrink M; Graf N; Spreafico F
Eur J Cancer; 2021 Feb; 144():113-122. PubMed ID: 33341445
[TBL] [Abstract][Full Text] [Related]
8. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.
Hol JA; Lopez-Yurda MI; Van Tinteren H; Van Grotel M; Godzinski J; Vujanic G; Oldenburger F; De Camargo B; Ramírez-Villar GL; Bergeron C; Pritchard-Jones K; Graf N; Van den Heuvel-Eibrink MM
PLoS One; 2019; 14(8):e0221373. PubMed ID: 31425556
[TBL] [Abstract][Full Text] [Related]
10. Paediatric renal tumours: perspectives from the SIOP-RTSG.
SIOP Renal Tumour Study Group
Nat Rev Urol; 2017 Jan; 14(1):3-4. PubMed ID: 27922041
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience.
Hol JA; Jongmans MCJ; Sudour-Bonnange H; Ramírez-Villar GL; Chowdhury T; Rechnitzer C; Pal N; Schleiermacher G; Karow A; Kuiper RP; de Camargo B; Avcin S; Redzic D; Wachtel A; Segers H; Vujanic GM; van Tinteren H; Bergeron C; Pritchard-Jones K; Graf N; van den Heuvel-Eibrink MM;
Cancer; 2021 Feb; 127(4):628-638. PubMed ID: 33146894
[TBL] [Abstract][Full Text] [Related]
12. Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocol.
Gooskens SL; Graf N; Furtwängler R; Spreafico F; Bergeron C; Ramírez-Villar GL; Godzinski J; Rübe C; Janssens GO; Vujanic GM; Leuschner I; Coulomb-L'Hermine A; Smets AM; de Camargo B; Stoneham S; van Tinteren H; Pritchard-Jones K; van den Heuvel-Eibrink MM;
Nat Rev Urol; 2018 May; 15(5):309-319. PubMed ID: 29485128
[TBL] [Abstract][Full Text] [Related]
13. Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG.
Fajardo RD; van den Heuvel-Eibrink MM; van Tinteren H; Spreafico F; Acha T; Bergeron C; de Camargo B; Oldenburger F; Rübe C; Oue T; Vokuhl C; de Krijger RR; Vujanic G; Sebire N; Coulomb-L'Hermine A; Collini P; Gandola L; Pritchard-Jones K; Graf N; Janssens GO; van Grotel M
Pediatr Blood Cancer; 2020 Feb; 67(2):e28039. PubMed ID: 31625685
[TBL] [Abstract][Full Text] [Related]
14. Adult Wilms tumour.
Zdrojowy R; Sawicz-Birkowska K; Apoznański W; Patkowski D; Szydełko T; Pietras W; Dembowski J
Int Urol Nephrol; 2011 Sep; 43(3):691-6. PubMed ID: 21110097
[TBL] [Abstract][Full Text] [Related]
15. Number of lymph nodes sampled in SFCE/SIOP 2001 patients with Wilms tumour: Is the goal of more than six achievable?
Irtan S; Coulomb-Lhermine A; Lanz C; Tabone MD; Pasqualini C; Dumont B; Thebaud E; Guellec I; Verschuur A
Pediatr Blood Cancer; 2023 Mar; 70(3):e30107. PubMed ID: 36453594
[TBL] [Abstract][Full Text] [Related]
16. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood.
Vujanić GM; Sandstedt B; Harms D; Kelsey A; Leuschner I; de Kraker J;
Med Pediatr Oncol; 2002 Feb; 38(2):79-82. PubMed ID: 11813170
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.
Hontecillas-Prieto L; Garcia-Dominguez DJ; Vaca DP; Garcia-Mejias R; Marcilla D; Ramirez-Villar GL; Saez C; de Álava E
Oncotarget; 2017 Feb; 8(7):11173-11186. PubMed ID: 28061436
[TBL] [Abstract][Full Text] [Related]
18. Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
Groenendijk A; van Tinteren H; Jiang Y; de Krijger RR; Vujanic GM; Godzinski J; Rübe C; Schenk JP; Morosi C; Pritchard-Jones K; Al-Saadi R; Vaidya SJ; Verschuur AC; Ramírez-Villar GL; Graf N; de Camargo B; Drost J; Perotti D; van den Heuvel-Eibrink MM; Brok J; Spreafico F; Mavinkurve-Groothuis AMC
Eur J Cancer; 2022 Mar; 163():88-97. PubMed ID: 35042071
[TBL] [Abstract][Full Text] [Related]
19. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
Green DM
Eur J Cancer; 2015 May; 51(8):993-4. PubMed ID: 25818548
[No Abstract] [Full Text] [Related]
20. Wilms tumour: prognostic factors, staging, therapy and late effects.
Kaste SC; Dome JS; Babyn PS; Graf NM; Grundy P; Godzinski J; Levitt GA; Jenkinson H
Pediatr Radiol; 2008 Jan; 38(1):2-17. PubMed ID: 18026723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]